Phone: 1+ 888-430-2221
OTCQB: CBBT   Cerebain Biotech Corp  

About Cerebain Biotech

Cerebain Biotech (OTC: CBBT) is dedicated to pursuing the development and commercialization of novel treatment approaches in the fight against dementias, with a particular focus on Alzheimer’s Disease.

Our vision is to apply what we know about the effect of omentum stimulation on improved cognitive function to create a new and more effective treatment paradigm. For the millions of people living with, or in fear of, an Alzheimer’s diagnosis, our success could mean hope for the future and a lifetime preserved. Our goal is the development and commercialization of a medical device with the potential to arrest or significantly slow Alzheimer’s Disease progression.

OTCQB: CBBT   Cerebain Biotech Corp